肺がんに対するEDGE非侵襲的腫瘍放射線手術

この投稿を共有する

米国におけるがん関連死亡

The American Cancer Society published its 2015 annual cancer statistics report online on January 5, 2015. The cancer death rate in the United States has fallen by 22% from its peak in 1991 to the present, which means that 1.5 million cancer patients have avoided death. The report also predicted the incidence and mortality of cancer in the United States in 2015.

肺癌, rectal cancer, prostate cancer, and breast cancer are the most common cancer deaths, accounting for almost half of the total cancer mortality, and lung cancer accounts for 27%. For 肺癌, the mortality rate of male patients decreased by 36% from 1991 to 2011, and female patients decreased by 11%. Breast cancer mortality has declined by 35% from the peak to date, while 前立腺癌 and rectal cancer have decreased by 47%.

EDGE 非侵襲的腫瘍除去放射線手術

Dr. Liao of the Henry Ford Hospital of the United States said that because American hospitals have the world’s most advanced technology and the most experts, the United States has been at the forefront of cancer treatment in the world. The introduction and use of the EDGE non-invasive 腫瘍 removal system has further improved the level of cancer treatment in the United States. And the five-year survival rate of cancer patients. The American Henry Ford Hospital Cancer Center is an American hospital with a team of 12 oncologists. Multidisciplinary experts work together to develop a personalized treatment plan for a patient to ensure that the treatment plan is comprehensive and effective.

The EDGE tumor non-invasive radiosurgery treatment system is a cancer treatment system approved by the US FDA in 2014. It is by far the most effective tumor radiosurgery system. It is difficult to perform routine surgery on tumors such as head tumors, lung cancer, spinal tumors, 肝臓がん and other solid tumors. It has a treatment effect that is difficult to achieve with conventional surgery and radiotherapy equipment, and is the best choice for cancer patients to remove tumor lesions so far.

Compared with conventional surgery and conventional chemotherapy, the EDGE tumor non-invasive surgical removal system has the following advantages:

1. Non-invasive: without any incision, the patient does not need to undergo huge trauma of surgery;

2. Short treatment time: about 10 minutes each treatment time, does not affect the patient’s quality of life;

3. Less treatment times: 1-5 times, once a day, without hospitalization;

4. High efficiency: Up to 5 tumors can be removed at the same time, and the tumor can be removed up to 5-175px, which is suitable for the removal of lesions in almost all patients with solid tumors;

5. Thoroughly: track and lock the escaped tumor and clear it every 10 milliseconds, completely eliminate the tumor cells;

6. High-intensity precision treatment: high-energy, 0.2-millimeter-level precision eliminates tumor cells, and almost no damage to surrounding important organs and tissues;

7. Convenience: no anesthesia and no hospitalization;

8. There are almost no side effects: the patient has no side effects of routine surgery and radiotherapy.

Comparison of EDGE with gamma knife and wave knife:

  1. Higher treatment intensity: EDGE radiation treatment intensity is more than 6 times that of gamma knife and wave knife, eliminating tumor cells more thoroughly.

  2. The treatment effect is better: 0.2 mm precision, dynamic and real-time tracking of tumor cells, the treatment effect is far better than the gamma knife and the wave knife.

  3. More tumor foci can be removed at a time: EDGE can remove up to 5 tumor foci at a time, and the treatment efficiency is higher, while gamma knife and wave knife can only remove one tumor foci at a time.

  4. Shorter time: EDGE resection of multiple brain metastases only takes about 10 minutes, while other radiation treatments such as gamma knife or wave knife take 1 to 5 hours.

  5. EDGE, almost no side effects of gamma knife and wave knife.

ニュースレターを購読する

Cancerfax から最新情報を入手し、ブログを見逃すことはありません

探検する詳細

ヒトベースの CAR T 細胞療法: 画期的な進歩と課題
CART細胞療法

ヒトベースの CAR T 細胞療法: 画期的な進歩と課題

ヒトベースのCAR T細胞療法は、がん細胞を標的にして破壊するように患者自身の免疫細胞を遺伝子組み換えすることにより、がん治療に革命をもたらします。これらの治療法は、体の免疫系の力を利用することで、さまざまな種類のがんの長期にわたる寛解を可能にする強力で個別化された治療法を提供します。

サイトカイン放出症候群を理解する: 原因、症状、治療
CART細胞療法

サイトカイン放出症候群を理解する: 原因、症状、治療

サイトカイン放出症候群 (CRS) は、免疫療法や CAR-T 細胞療法などの特定の治療によって引き起こされることが多い免疫系反応です。これにはサイトカインの過剰な放出が含まれ、発熱や倦怠感から臓器損傷など生命を脅かす可能性のある合併症まで、さまざまな症状を引き起こします。管理には慎重な監視と介入戦略が必要です。

助けが必要? 私たちのチームはあなたを支援する準備ができています。

私たちはあなたの愛する人と近くの人の迅速な回復を願っています。

チャットを始める
私たちはオンラインです!私たちとしゃべる!
コードをスキャンする
こんにちは、

CancerFaxへようこそ!

CancerFax は、進行期がんに直面している個人を、CAR T 細胞療法、TIL 療法、臨床試験などの画期的な細胞療法と世界中で結び付けることに特化した先駆的なプラットフォームです。

私たちがあなたのために何ができるかをお知らせください。

1) 海外でのがん治療は?
2) CAR-T細胞療法
3) がんワクチン
4) オンラインビデオ相談
5) 陽子線治療